How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,313 results for

Six Item Cognitive Impairment Test


Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Fibromyalgia

no exercise or another intervention. Major outcomes were health-related quality of life (HRQL), pain intensity, stiffness, fatigue, physical function, withdrawals, and adverse 2017 6. Is cognitive behavioral therapy (CBT) an effective treatment for fibromyalgia ? Is cognitive behavioral therapy (CBT) an effective treatment for fibromyalgia ? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work (...) : Fibromyalgia is a debilitating chronic disease characterized by musculoskeletal pain, fatigue, and compromises (...) in cognition. One of the biggest challenges surrounding fibromyalgia is proper diagnosis, as there is no current diagnostic test established. Most practitioners utilize examining tender points and other subjective self-assessments to aid in the assessment of the condition. Current therapies include both medication and non-pharmacologic such as chiropractic therapy, acupuncture, aerobic

2018 Trip Latest and Greatest

182. International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS)

One Screening, diagnostic assessment, risk assessment and life-stage 35 1.1 Irregular cycles and ovulatory dysfunction 36 1.2 Biochemical hyperandrogenism 38 1.3 Clinical hyperandrogenism 40 1.4 Ultrasound and polycystic ovarian morphology 42 1.5 Anti-Müllerian Hormone (AMH) 45 1.6 Ethnic variation 46 1.7 Menopause life-stage 47 1.8 Cardiovascular disease 48 1.9 Gestational diabetes, impaired glucose tolerance and type 2 diabetes 50 1.10 Obstructive sleep apnea 53 1.11 Endometrial cancer 55 (...) pharmacological agents 97 4.7 Inositol 99 Chapter Five Assessment and treatment of infertility 100 5.1a Assessment of factors that may affect fertility, treatment response or pregnancy outcomes 101 5.1b Tubal patency testing 103 5.2 Ovulation induction principles 104 5.3 Letrozole 105 5.4 Clomiphene citrate and/or metformin 107 5.5 Gonadotrophins 110 5.6 Anti-obesity agents 112 5.7 Laparoscopic ovarian surgery 113 5.8 Bariatric surgery 115 5.9a In-vitro fertilisation 117 5.9b Gonadotropin releasing hormone

2018 European Society of Human Reproduction and Embryology

183. Management of Cardiovascular Diseases during Pregnancy

and offspring complications 3174 3.3.3 Pregnancy heart team 3176 3.4 Cardiovascular diagnosis in pregnancy 3176 3.4.1 Electrocardiography 3176 3.4.2 Echocardiography 3176 3.4.3 Exercise testing 3177 3.4.4 Ionizing radiation exposure 3177 3.4.5 Chest radiography and computed tomography 3177 3.4.6 Cardiac catheterization 3177 3.4.7 Magnetic resonance imaging 3177 3.5 Genetic testing and counselling 3177 3.5.1 Pre-natal diagnosis 3178 3.6 Foetal assessment 3178 3.6.1 Screening for congenital heart disease 3178 (...) Ventricular tachycardia 3203 9.7 Bradyarrhythmias 3204 9.7.1 Sinus node dysfunction 3204 9.7.2 Atrioventricular block 3204 9.8 Interventions 3204 9.8.1 Electrical cardioversion 3204 9.8.2 Catheter ablation 3204 9.8.3 Implantable cardioverter-defibrillator and pacing 3204 9.9 Recommendations 3206 10. Hypertensive disorders 3207 10.1 Diagnosis and risk assessment 3207 10.1.1 Blood pressure measurement 3207 10.1.2 Laboratory tests 3207 10.2 Definition and classification of hypertension in pregnancy 3207 10.3

Full Text available with Trip Pro

2018 European Society of Cardiology

184. Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

emotional, psychological, cognitive and/ or spiritual distress have access to psychiatrists, social workers, psychologists, and/or spiritual care providers. 3.3 Patients experiencing physical, functional, rehabilitative, and/ or nutritional concerns have access to occupational therapists, physiotherapists, registered dietitians and/or speech language pathologists. 3.4 Regional Cancer Programs ensure continuity of care for all patients, regardless of where they receive their cancer treatment. 3.5 (...) population (10-13) . Their families and caregivers may also be affected by the disease, experiencing emotional and psychological distress, shifting roles, increasing responsibilities, financial burden and caregiver stress (14) (See Table 1 for a summary of patients’ and families’ psychosocial concerns). Category Concern Cognitive • Brain fog • Delirium • Preexisting and worsening cognitive issues (e.g., due to dementia, brain tumours • Capacity (consent to treatment and medical assistance in dying

2018 Cancer Care Ontario

185. Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies

measures Indicators Targets Cuba (2103) (23) • Performance measures for the strategy (referred to as objectives in the strategy) include: 1) improve care for dementia patients and their families; 2) prevent cognitive impairment and dementia; 3) detect cognitive impairment early; 4) reduce stigma around dementia; 5) increase professional development; 6) train families in patient care; 7) promote basic, clinical and epidemiological research on dementia; and 8) familiarize health teams with laws (...) protecting the rights of older adults and people with cognitive impairment. • Indicators were divided by input (structure), process and outcomes indicators. 1) Input (structure) o existence of municipal memory clinic; o existence of a memory clinic in every polyclinic; o easy access to memory clinics and removal of architectural barriers in health centres; o existence of school for caregivers in each health area served by a polyclinic; o existence of senior centres for patients with mental incapacity

2018 McMaster Health Forum

186. Deployment of personnel to military operations: impact on mental health and social functioning

interpretation in the sense of measuring the effect of deployment on PTSD. 13 The Campbell Collaboration | physically and mentally impair those directly engaged in combat and those engaged in support functions, there are a number of reasons why the extent of this issue is arguably of even greater importance now. First, the types of security threats and military operations have changed substantially since 1989. The fall of the Iron Curtain released the tight grip of the former (...) in the US deployments are of 4 month duration. Within these expected deployment lengths duration may vary considerably from sometimes only a few days to well above a year (US Army, 2011). Both troop demands and the nature of operations affect the length of deployment. Generally, however, deployment length varies between six and 12 months. Street et al. (2009) argue that mental “resilience” may decrease over time, therefore the period of time between multiple deployments and the number of deployments may

2018 Campbell Collaboration

187. Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

; MOS, Medical Outcomes Study; PAD, peripheral artery disease; PADQOL, Impact of PAD on Quality of Life Questionnaire ; PAQ, Peripheral Artery Questionnaire , ; SF, Short Form; 6-MWT, 6-minute walk test; VascuQoL, Vascular Quality of Life Questionnaire ; and WIQ, Walking Impairment Questionnaire. , , Questionnaire measures do not always improve even when treadmill walking performance or 6-MWT improves. For example, in the CLEVER randomized trial (Claudication: Exercise Versus Endoluminal (...) as a reproducible discomfort or fatigue in the muscles of the lower extremity that occurs with exertion and is relieved within 10 minutes of rest. Most people with PAD do not have classic claudication symptoms but still have significantly greater functional impairment and decline than people without PAD. This significant physical activity limitation results in functional impairment, mobility loss, and decreased quality of life. Improving functioning and quality of life is a major goal in the treatment

Full Text available with Trip Pro

2019 American Gastroenterological Association Institute

188. Identifying Effective Approaches to Support Parents and Caregivers of Children with Fetal Alcohol Spectrum Disorder

and therapy • One recent low-quality review aimed to identify programs targeted at families of children with physical disabilities and/or intellectual impairments and found education and counselling services delivered either online and in group settings as one possible approach.(7) • Two primary studies conducted in Ontario found Acceptance and Commitment Therapy (ACT) improved depression and stress among caregivers, reported health status, and psychological flexibility, as well as reduced cognitive (...) and disabilities resulting from alcohol exposure in utero.”(1) FASD affects fetal and brain development and may result in limitations to any of an individual’s: memory; sensory integration; social communication; language processing; emotional regulation; adaptive functioning; and other executive functions that may make conforming to social, behavioural and cognitive expectations difficult.(2; 3) These effects may mean that individuals affected by FASD are unable to live independently, have difficulty securing

2018 McMaster Health Forum

189. Managing health and wellbeing in the workplace

using selected key words within the advanced search functions of Google/Google Scholar and limited to the first 200 results in keeping with evidence-based guidance. Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) protocols were used with transparent reporting of search strategy and study retrieval (details in Appendices). 8 MANAGING HEALTH AND WELLBEING IN THE WORKPLACE| SAX INSTITUTE Evidence grading The review adopted the protocol used by the US Community Preventive (...) musculoskeletal disorders and symptoms, and moderate evidence that stakeholder participation and work modification are more effective and cost effective at returning to work adults with musculoskeletal conditions than other workplace-linked interventions. Evidence on the contribution of wellness programs to productivity is patchy. The Total Worker Health™(TWH) model has been used to develop the Employer Health and Productivity RoadMap™. The Roadmap comprises six interrelated and integrated core elements: (i

2018 Sax Institute Evidence Check

190. Depression and anxiety programs for children and young people

psychological interventions, although the returns are lower than widely implemented health care interventions. DEPRESSION AND ANXIETY PROGRAMS FOR CHILDREN AND YOUNG PEOPLE | SAX INSTITUTE 7 Six other programs were identified as having sufficient evidence to warrant a 2 or 3 thumb rating. These were: Coping Cat ( ? ? ?); Families and Schools Together ( ? ?); Physical activity interventions ( ? ?); the Good Behaviour Game ( ? ?); Mentoring ( ? ?); and Online CBT ( ? ?). All of these programs have been (...) be partly related to differences in implementation models rather than program content. For example, a number of the Australian programs (Aussie Optimism, FRIENDS, Resourceful Adolescent Program) that were implemented by school staff had weak effects. To improve the evidence for Australian psychological interventions, future evaluations should competitively test the effects of different implementation models. For example, it may be feasible to test whether effects improve when psychologists, mental

2018 Sax Institute Evidence Check

191. WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents

of an individual patient’s pain requires careful assessment as described in item 2 above, plus differential diagnosis of the type of pain (e.g. nociceptive somatic pain or nociceptive visceral pain or neuropathic pain), the site of origin of the pain and a decision about optimum treatment. The correct dose is the dose that relieves the patient’s pain to a level acceptable to the patient. Previous WHO guidance included a pain management ladder which has been widely used in the cancer care community (See http

2019 World Health Organisation Guidelines

192. Developing a Value Framework for Genetic Diagnosis: Part I A Systematic Review of Outcomes Hierarchies and Measurement Approaches

or models that can be applied and validated for use in genetic diagnoses. KQ2: What can be learned from existing value frameworks in health care? Eighteen relevant articles/documents (six rated Good) were identified. Several sources defined ‘value’ in the health care setting, and in general these were quite consistent. All considered it a ratio of some measure of health benefit, quality or outcomes and financial resources (dollars, costs, money spent). Components of value identified also included (...) ; and the need to make the case for the value of genetic services to payer and policy-makers. KQ4: What are specific health outcomes and how does a diagnosis contribute to improved short- and long-term outcomes for a) patients, b) family members and c) health care delivery systems and/or public health programs? Sixty-seven articles/documents (32 rated Good) were considered relevant. Six outcome hierarchies were identified, but only two focused on health outcomes. Hierarchies included health outcomes

2019 American College of Medical Genetics and Genomics

193. WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights

through which people can be empowered to prevent, test for and treat disease themselves. Many health issues can already be dealt with through self-care and the list continues to grow. A people-centred approach supports health literacy so that people can take charge of their own health with evidence- based self-care interventions. When people have agency and autonomy, they can make and enact decisions in all aspects of their lives, including in relation to sexuality and reproduction. Self-care (...) Grading of Recommendations Assessment, Development and Evaluation GRC Guidelines Review Committee GVPS Global Values and Preferences Survey HIVST HIV self-testing HPV human papillomavirus HPVSS HPV self-sampling HRP The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction IPCHS Integrated People-Centred Health Services framework MEC Medical eligibility criteria for contraceptive use (WHO publication) OCP oral contraceptive pill OPK

2019 World Health Organisation Guidelines

194. WHO Guideline: recommendations on digital interventions for health system strengthening

in technology. From the development of modern sanitation to the advent of penicillin, anesthesia, vaccines and magnetic resonance imaging, science, research and technology have always been key drivers of better health. It’s no different today. Advances in technology are continuing to push back the boundaries of disease. Digital technologies enable us to test for diabetes, HIV and malaria on the spot, instead of sending samples off to a laboratory. 3-D printing is revolutionizing the manufacture of medical (...) and affordability of health services. However, shortfalls remain in ensuring access to all who need health services and in ensuring that they are delivered with the intended quality without causing financial hardship to the people accessing them. The Tanahashi framework published by WHO in 1978 provides a time-tested model for understanding health system performance gaps and how they prevent the intended coverage, quality and affordability of health services. This cascading model illustrates how health systems

2019 World Health Organisation Guidelines

195. Male Sexual Dysfunction

., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res, 1999. 11: 319. 89. Mulhall, J.P., et al. Validation of the erection hardness score. J Sex Med, 2007. 4: 1626. 90. Whooley, M.A., et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med, 1997. 12: 439. 91. Khera, M., et al. Diagnosis and Treatment of Testosterone (...) Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med, 2016. 13: 1787. 92. Davis-Joseph, B., et al. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology, 1995. 45: 498. 93. Ghanem, H.M., et al. SOP: physical examination and laboratory testing for men with erectile dysfunction. J Sex Med, 2013. 10: 108. 94. Bhasin, S., et al. Testosterone therapy in men with androgen deficiency

2019 European Association of Urology

196. Chronic Pelvic Pain

., et al. Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev, 2007. 27: 798. 54. Walker, E.A., et al. Psychiatric diagnoses and sexual victimization in women with chronic pelvic pain. Psychosomatics, 1995. 36: 531. 55. Nickel, J.C., et al. Childhood sexual trauma in women with interstitial cystitis/bladder pain syndrome: a case control study. Can Urol Assoc J, 2011. 5: 410. 56. Paras, M.L., et al. Sexual abuse and lifetime (...) ., et al. Associations Between Penetration Cognitions, Genital Pain, and Sexual Well-being in Women with Provoked Vestibulodynia. J Sex Med, 2016. 13: 444. 93. Roth, R.S., et al. Psychological factors and chronic pelvic pain in women: a comparative study with women with chronic migraine headaches. Health Care Women Int, 2011. 32: 746. 94. Souza, P.P., et al. Qualitative research as the basis for a biopsychosocial approach to women with chronic pelvic pain. J Psychosom Obstet Gynaecol, 2011. 32: 165

2019 European Association of Urology

197. Neuro-urology

, D.S. A questionnaire to assess neurological impairment in multiple sclerosis. Mult Scler, 1998. 4: 444. 87. Foley, F.W., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample. Mult Scler, 2013. 19: 1197. 88. Sanders, A.S., et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19). Sex Disabil, 2000. 18: 3. 89. Marrie, R.A., et al. Validity and reliability of the MSQLI in cognitively (...) , 2008. 27: 22. 21. Kim, M., et al. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease. Parkinsonism Relat Disord, 2015. 21: 205. 22. Sakakibara, R., et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn, 2015. 23. Yamamoto, T., et al. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. J Neurol

2019 European Association of Urology

198. Prostate Cancer

in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening. J Urol, 2016. 195: 66. 91. Grossman, D.C., et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. Jama, 2018. 319: 1901. 92. U.S. Preventive Services, Task Force. Prostate Cancer Screening Draft Recommendations. 2017. 93. Arnsrud Godtman, R., et al. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 (...) years in the Goteborg randomized population-based prostate cancer screening trial. Eur Urol, 2015. 68: 354. 94. Ilic, D., et al. Screening for prostate cancer. Cochrane Database Syst Rev, 2013. 1: CD004720. 95. Hayes, J.H., et al. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA, 2014. 311: 1143. 96. Booth, N., et al. Health-related quality of life in the Finnish trial of screening for prostate cancer. Eur Urol, 2014. 65: 39. 97. Vasarainen, H

2019 European Association of Urology

200. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder

) and the Department of Defense (DoD) released an updated clinical practice guideline (CPG) on the treatment of PTSD. 9 This CPG was based on literature available through March 2016, and it addressed pharmacologic and nonpharmacologic (including complementary and integrative health) interventions for PTSD. 9 The CPG recommended individual, manualized trauma-focused psychotherapy with exposure and/or cognitive restructuring, such as prolonged exposure (PE), cognitive processing therapy (CPT), eye movement (...) desensitization and reprocessing (EMDR), specific cognitive behavioral therapies (CBT) for PTSD, brief eclectic psychotherapy (BEP), narrative exposure therapy (NET), and written narrative exposure. If trauma-focused psychotherapy is not readily available or not preferred, the CPG recommended individual non-trauma-focused psychotherapy or pharmacotherapy. Currently, only the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine are approved by the U.S. Food and Drug Administration (FDA

2019 Effective Health Care Program (AHRQ)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>